Drug Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples), By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges), By Region and Competition, 2020-2030F
The Global Drug Screening Market, valued at USD 5.56 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 7.58 Billion by 2030. The global drug screening market is defined by the development, production, and distribution of testing solutions designed to detect illicit substances, controlled medications, and their metabolites in biological samples. This market's growth is primarily driven by the escalating global incidence of substance abuse and stringent regulatory mandates for drug testing across diverse sectors, including workplaces and transportation.
Key Market Drivers
The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.
Key Market Challenges
The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.
Key Market Trends
Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.
Key Market Players
In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.
Available Customizations:
Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The global drug screening market is significantly influenced by the escalating rates of substance abuse worldwide. As illicit drug use continues to rise, there is a corresponding surge in the demand for effective screening solutions across various sectors, including healthcare, workplaces, and criminal justice. This heightened prevalence of drug use necessitates robust detection methods to safeguard public health and maintain societal order. According to the UNODC World Drug Report 2024, the number of people who use drugs globally rose to 292 million in 2022, marking a 20 percent increase over the preceding decade. This trend directly fuels the need for expanded drug testing programs, driving both the volume of tests performed and the innovation required to detect a broader spectrum of substances.
Key Market Challenges
The continuous emergence of novel synthetic drugs and designer substances presents a substantial impediment to the growth of the global drug screening market. These rapidly evolving compounds frequently bypass existing detection methodologies, requiring constant and significant analytical innovation from screening providers. This dynamic landscape compels market participants to dedicate substantial resources to ongoing research and development efforts, increasing operational costs and extending timelines for test kit validation and deployment.
Key Market Trends
Technological advancements are profoundly influencing the global drug screening market by improving test speed, accuracy, and the range of detected substances. Innovations in analytical techniques are crucial, especially as attempts to compromise test integrity rise. The 2024 Quest Diagnostics Drug Testing Index reported tampered drug tests in the general U. S. workforce increased over six-fold in 2023 from the prior year, underscoring the demand for robust screening methods. This drives the development of advanced portable devices and laboratory platforms.
Key Market Players
- Quest Diagnostics Inc.
- Heska Corporation
- Thermo Fisher Scientific, Inc.
- Alfa Scientific Designs, Inc.
- OraSure Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- MPD Inc.
- Shimadzu Corporation
- Lifeloc Technologies, Inc.
- Dr?gerwerk AG & Co. KGaA
- Premier Biotech, Inc.
- Omega Laboratories, Inc.
In this report, the Global Drug Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Drug Screening Market, By Product & Services:
- Drug Screening Product
- Analytical Instruments
- Rapid Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Drug Screening Service
- Drug Screening Market, By Sample Type:
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other Samples
- Drug Screening Market, By End User:
- Drug Testing Laboratories
- Workplaces
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools and Colleges
- Drug Screening Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Drug Screening Market.
Available Customizations:
Global Drug Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL DRUG SCREENING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA DRUG SCREENING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Services
6.2.2. By Sample Type
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Screening Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Services
6.3.1.2.2. By Sample Type
6.3.1.2.3. By End User
6.3.2. Canada Drug Screening Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Services
6.3.2.2.2. By Sample Type
6.3.2.2.3. By End User
6.3.3. Mexico Drug Screening Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Services
6.3.3.2.2. By Sample Type
6.3.3.2.3. By End User
7. EUROPE DRUG SCREENING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Services
7.2.2. By Sample Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Services
7.3.1.2.2. By Sample Type
7.3.1.2.3. By End User
7.3.2. France Drug Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Services
7.3.2.2.2. By Sample Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Drug Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Services
7.3.3.2.2. By Sample Type
7.3.3.2.3. By End User
7.3.4. Italy Drug Screening Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Services
7.3.4.2.2. By Sample Type
7.3.4.2.3. By End User
7.3.5. Spain Drug Screening Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Services
7.3.5.2.2. By Sample Type
7.3.5.2.3. By End User
8. ASIA PACIFIC DRUG SCREENING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Services
8.2.2. By Sample Type
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Services
8.3.1.2.2. By Sample Type
8.3.1.2.3. By End User
8.3.2. India Drug Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Services
8.3.2.2.2. By Sample Type
8.3.2.2.3. By End User
8.3.3. Japan Drug Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Services
8.3.3.2.2. By Sample Type
8.3.3.2.3. By End User
8.3.4. South Korea Drug Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Services
8.3.4.2.2. By Sample Type
8.3.4.2.3. By End User
8.3.5. Australia Drug Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Services
8.3.5.2.2. By Sample Type
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA DRUG SCREENING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Services
9.2.2. By Sample Type
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Screening Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Services
9.3.1.2.2. By Sample Type
9.3.1.2.3. By End User
9.3.2. UAE Drug Screening Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Services
9.3.2.2.2. By Sample Type
9.3.2.2.3. By End User
9.3.3. South Africa Drug Screening Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Services
9.3.3.2.2. By Sample Type
9.3.3.2.3. By End User
10. SOUTH AMERICA DRUG SCREENING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Services
10.2.2. By Sample Type
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Services
10.3.1.2.2. By Sample Type
10.3.1.2.3. By End User
10.3.2. Colombia Drug Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Services
10.3.2.2.2. By Sample Type
10.3.2.2.3. By End User
10.3.3. Argentina Drug Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Services
10.3.3.2.2. By Sample Type
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL DRUG SCREENING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Quest Diagnostics Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Heska Corporation
15.3. Thermo Fisher Scientific, Inc.
15.4. Alfa Scientific Designs, Inc.
15.5. OraSure Technologies, Inc.
15.6. F. Hoffmann-La Roche Ltd
15.7. MPD Inc.
15.8. Shimadzu Corporation
15.9. Lifeloc Technologies, Inc.
15.10. Dr?gerwerk AG & Co. KGaA
15.11. Premier Biotech, Inc.
15.12. Omega Laboratories, Inc.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL DRUG SCREENING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product & Services (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
5.2.2. By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples)
5.2.3. By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA DRUG SCREENING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product & Services
6.2.2. By Sample Type
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Screening Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product & Services
6.3.1.2.2. By Sample Type
6.3.1.2.3. By End User
6.3.2. Canada Drug Screening Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product & Services
6.3.2.2.2. By Sample Type
6.3.2.2.3. By End User
6.3.3. Mexico Drug Screening Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product & Services
6.3.3.2.2. By Sample Type
6.3.3.2.3. By End User
7. EUROPE DRUG SCREENING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product & Services
7.2.2. By Sample Type
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product & Services
7.3.1.2.2. By Sample Type
7.3.1.2.3. By End User
7.3.2. France Drug Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product & Services
7.3.2.2.2. By Sample Type
7.3.2.2.3. By End User
7.3.3. United Kingdom Drug Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product & Services
7.3.3.2.2. By Sample Type
7.3.3.2.3. By End User
7.3.4. Italy Drug Screening Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product & Services
7.3.4.2.2. By Sample Type
7.3.4.2.3. By End User
7.3.5. Spain Drug Screening Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product & Services
7.3.5.2.2. By Sample Type
7.3.5.2.3. By End User
8. ASIA PACIFIC DRUG SCREENING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product & Services
8.2.2. By Sample Type
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Drug Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product & Services
8.3.1.2.2. By Sample Type
8.3.1.2.3. By End User
8.3.2. India Drug Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product & Services
8.3.2.2.2. By Sample Type
8.3.2.2.3. By End User
8.3.3. Japan Drug Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product & Services
8.3.3.2.2. By Sample Type
8.3.3.2.3. By End User
8.3.4. South Korea Drug Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product & Services
8.3.4.2.2. By Sample Type
8.3.4.2.3. By End User
8.3.5. Australia Drug Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product & Services
8.3.5.2.2. By Sample Type
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA DRUG SCREENING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product & Services
9.2.2. By Sample Type
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Screening Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product & Services
9.3.1.2.2. By Sample Type
9.3.1.2.3. By End User
9.3.2. UAE Drug Screening Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product & Services
9.3.2.2.2. By Sample Type
9.3.2.2.3. By End User
9.3.3. South Africa Drug Screening Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product & Services
9.3.3.2.2. By Sample Type
9.3.3.2.3. By End User
10. SOUTH AMERICA DRUG SCREENING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product & Services
10.2.2. By Sample Type
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product & Services
10.3.1.2.2. By Sample Type
10.3.1.2.3. By End User
10.3.2. Colombia Drug Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product & Services
10.3.2.2.2. By Sample Type
10.3.2.2.3. By End User
10.3.3. Argentina Drug Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product & Services
10.3.3.2.2. By Sample Type
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL DRUG SCREENING MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Quest Diagnostics Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Heska Corporation
15.3. Thermo Fisher Scientific, Inc.
15.4. Alfa Scientific Designs, Inc.
15.5. OraSure Technologies, Inc.
15.6. F. Hoffmann-La Roche Ltd
15.7. MPD Inc.
15.8. Shimadzu Corporation
15.9. Lifeloc Technologies, Inc.
15.10. Dr?gerwerk AG & Co. KGaA
15.11. Premier Biotech, Inc.
15.12. Omega Laboratories, Inc.
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
